持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/01/08 | 日証協 | 141,119株 | +84.84% | 75,986株 | +327.22% | 85,103株 | +190.61% | 10,500株 | -62.66% |
2015/12/30 | 日証協 | 76,347株 | +10.35% | 17,786株 | +151.78% | 29,284株 | 0% | 28,119株 | +255.94% |
2015/12/25 | 日証協 | 69,189株 | -46.65% | 7,064株 | -93.15% | 29,284株 | -64.21% | 7,900株 | -57.07% |
2015/12/18 | 日証協 | 129,698株 | +47.33% | 103,175株 | +1126.96% | 81,815株 | +29.42% | 18,400株 | +93.3% |
2015/12/11 | 日証協 | 88,032株 | +10.27% | 8,409株 | -79.03% | 63,215株 | +17.91% | 9,519株 | -18.26% |
2015/12/04 | 日証協 | 79,832株 | +1.91% | 40,091株 | +225.7% | 53,615株 | +5.93% | 11,646株 | +147.79% |
2015/11/27 | 日証協 | 78,332株 | +8.45% | 12,309株 | -67.78% | 50,615株 | +0.6% | 4,700株 | +56.67% |
2015/11/20 | 日証協 | 72,232株 | +132.03% | 38,200株 | +1908.41% | 50,315株 | +280.74% | 3,000株 | -71.04% |
2015/11/13 | 日証協 | 31,130株 | -55.13% | 1,902株 | -94.94% | 13,215株 | -78.02% | 10,359株 | +227.92% |
2015/11/06 | 日証協 | 69,371株 | +3.16% | 37,600株 | +1068.43% | 60,115株 | -4.71% | 3,159株 | -27.53% |
2015/10/30 | 日証協 | 67,245株 | -3.09% | 3,218株 | -91.83% | 63,089株 | -1.78% | 4,359株 | +28.21% |
2015/10/23 | 日証協 | 69,386株 | -1.5% | 39,404株 | -2.05% | 64,230株 | -8.23% | 3,400株 | -11.89% |
2015/10/16 | 日証協 | 70,445株 | -11.93% | 40,230株 | +538.57% | 69,989株 | -5.58% | 3,859株 | -52.36% |
2015/10/09 | 日証協 | 79,984株 | -29.47% | 6,300株 | -92.57% | 74,128株 | -28.49% | 8,100株 | -64.78% |
2015/10/02 | 日証協 | 113,410株 | -2.33% | 84,738株 | +116.41% | 103,654株 | +1.67% | 23,001株 | -53.7% |
2015/09/25 | 日証協 | 116,111株 | +22.85% | 39,156株 | -28.21% | 101,951株 | +49.16% | 49,681株 | +766.58% |
2015/09/18 | 日証協 | 94,511株 | -2.24% | 54,539株 | +5.32% | 68,351株 | -13.74% | 5,733株 | -82.14% |
2015/09/11 | 日証協 | 96,678株 | -23.09% | 51,783株 | -44.59% | 79,236株 | -19.28% | 32,100株 | +75.41% |
2015/09/04 | 日証協 | 125,697株 | +31.33% | 93,461株 | +570.93% | 98,158株 | +14.47% | 18,300株 | -48.04% |
※株式分割は考慮していませんのでご注意ください。
Page Top